Maxime Cournot Selected Research

Myocardial Infarction

1/2018	Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus.
1/2010	Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department.
7/2006	Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys.
2/2005	Ozone air pollution is associated with acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maxime Cournot Research Topics

Disease

4	Myocardial Infarction 01/2018 - 02/2005
4	Chest Pain (Chest Pains) 05/2012 - 01/2010
3	Type 2 Diabetes Mellitus (MODY) 10/2018 - 01/2017
3	Acute Coronary Syndrome 10/2011 - 01/2010
2	Stroke (Strokes) 01/2018 - 01/2018
2	Hyperglycemia 01/2018 - 01/2017
2	Non-ST Elevated Myocardial Infarction 05/2012 - 10/2011
2	Heart Failure 06/2008 - 01/2007
1	Sepsis (Septicemia) 01/2021
1	Infarction (Infarctions) 01/2018
1	Hemolysis 01/2018
1	Ischemia 01/2018
1	Reperfusion Injury 01/2018
1	Vascular Diseases (Vascular Disease) 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2010
1	ST Elevation Myocardial Infarction 05/2009
1	Retinal Detachment (Retinal Detachments) 02/2009
1	Scoliosis 08/2008
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 08/2008
1	Congenital Abnormalities (Deformity) 08/2008
1	Acromegaly 08/2007
1	Growth Hormone-Secreting Pituitary Adenoma 08/2007
1	Brain Diseases (Brain Disorder) 03/2007
1	Diarrhea 03/2007
1	Poisoning 03/2007
1	Mushroom Poisoning 03/2007
1	Coronary Disease (Coronary Heart Disease) 07/2006
1	Chronic Hepatitis C 06/2004
1	Substance-Related Disorders (Drug Abuse) 06/2004
1	Hepatitis C 06/2004
1	Infections 06/2004
1	Fibrosis (Cirrhosis) 06/2004
1	Sarcopenia 08/2003

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 10/2018 - 01/2017
3	ischemia-modified albuminIBA 01/2018 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 07/2011
2	Fatty Acid Binding Protein 3IBA 10/2011 - 01/2010
2	LipidsIBA 02/2009 - 07/2006
2	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2008 - 01/2007
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2018
1	Advanced Oxidation Protein Products (AOPP)IBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2017
1	FructosamineIBA 01/2017
1	Sulfhydryl Compounds (Thiols)IBA 01/2017
1	AlbuminsIBA 01/2017
1	TroponinIBA 05/2012
1	Troponin IIBA 05/2012
1	ImmunosorbentsIBA 10/2011
1	EnzymesIBA 10/2011
1	Blood Glucose (Blood Sugar)IBA 07/2011
1	Hyaluronic Acid (Hyaluronan)IBA 02/2009
1	CeramidesIBA 02/2009
1	Retinaldehyde (Retinal)IBA 02/2009
1	Growth Hormone (Somatotropin)IBA 08/2008
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2006
1	Air Pollutants (Pollutants, Air)IBA 02/2005
1	OzoneIBA 02/2005
1	Transaminases (Aminotransferases)IBA 06/2004
1	Pharmaceutical PreparationsIBA 06/2004
1	Indicators and Reagents (Reagents)IBA 08/2003

Therapy/Procedure

5	Therapeutics 01/2018 - 06/2004
1	Thrombectomy 01/2018
1	Liver Transplantation 03/2007
1	Transplantation 03/2007
1	Aftercare (After-Treatment) 06/2004